Korean GP Credian sponsors $200m US SPAC offering
Seoul-based private equity firm Credian Partners has teamed up with CrystalBioSciences, a captive VC unit of biopharmaceutical company CrystalGenomics, to raise USD 200m for a US-listed special purpose acquisition company (SPAC).
Valuence Merger Corp. I is said to be the first Korean-sponsored SPAC to trade on NASDAQ. It will pursue merger targets in Asia – excluding Greater China – that are involved in life sciences or sustainability-related...
More on North Asia
Latest News
AVCJ Awards 2022: Exit of the Year – IPO: GoTo
GoTo’s rocky start on the Indonesia Stock Exchange betrays the pioneering nature of the listing and cements a legacy as an ecosystem lynchpin. Long-time backer Openspace Ventures reflects
New Zealand hydrogen player raises $14m
New Zealand hydrogen and zero-emission technologies developer Fabrum has raised a NZD 23m (USD 14.5m) Series A round led by UK-based AP Ventures.
Japan's Baseconnect gets $41m Series B
Japanese corporate contact and recruitment database provider Baseconnect has raised a JPY 5.4bn (USD 41m) Series B round led by Z Venture Capital (ZVC), formerly YJ Capital.
Carlyle launches tender offer for Japan's Iwasaki Electric
Iwasaki Electric, a Japanese lighting solutions provider that has worked on projects ranging from sports stadiums to hospitals, is set to be acquired by The Carlyle Group through a tender offer at a valuation of JPY 34.9bn (USD 266m).